CA inhibition studies revealed a good selectivity towards tumour-associated CAs IX and XII (Ki within the mid-nanomolar range in most of the cases) in comparison with CAs I, II, IV, and VII (Ki > 10 μM); CA IX was found to be slightly more sensitive towards structural changes. The gene discussed is CA1; the disease is neoplasm.